Skip to main content
Premium Trial:

Request an Annual Quote

Michael Dougherty

Foundation Medicine has appointed Michael Dougherty to its board of directors. He will fill an existing vacancy on the board and will initially join the board's audit committee. Dougherty most recently served as the executive chairman of Celator Pharmaceuticals, until its acquisition by Jazz Pharmaceuticals in July 2016. Previously, he served in a variety of senior positions, including chief operating officer of Genomics Collaborative, chief executive officer of Magainin Pharmaceuticals, and chief financial officer at Centocor.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.